Home
>
National Drug Code (NDC)
>
mitoXANTRONE
mitoXANTRONE - 0703-4685-01 - (mitoXANTRONE)
Drug Information of mitoXANTRONE
| Product NDC: | 0703-4685 |
| Proprietary Name: | mitoXANTRONE |
| Non Proprietary Name: | mitoXANTRONE |
| Active Ingredient(s): | 2 mg/mL & nbsp; mitoXANTRONE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of mitoXANTRONE
| Product NDC: | 0703-4685 |
| Labeler Name: | Teva Parenteral Medicines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077356 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060411 |
Package Information of mitoXANTRONE
| Package NDC: | 0703-4685-01 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-4685-01) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Information of mitoXANTRONE
| NDC Code | 0703-4685-01 |
| Proprietary Name | mitoXANTRONE |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-4685-01) > 10 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 0703-4685 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mitoXANTRONE |
| Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20060411 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc |
| Substance Name | MITOXANTRONE HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
